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A B S T R A C T
In this study we analyzed the prevalence of the odontogenic keratocyst (OKC) associated with impacted third molars
and evaluated OKC reactivity with the antibodies against cytokeratins (CK), particulary for CK10. Tissue samples were
obtained from the proximity of the impacted molar. Differences between genders, age groups and localization of cysts
were assessed using the c2-test and relative risk (RR), and associated confidence interval. Cysts were found in 75 cases,
and the radicular ones prevailed (63%), followed by follicular and OKC (13% and 12% respectively). The RR for the up-
per jaw cysts was almost twice greater than for the mandible. For the OKC exclusively, the upper-lower jaw RR was 1:2.
The RR for all cysts increases with age, while decreases for the OKCs. The risk for the OKC occurrence decreased with
age, with no significant differences between age groups. Finally, based on the results from this study we cannot suggest
that the CK10 staining should be considered an useful marker in differential diagnosis of the OKCs.
Key words: occurrence, localization, relative risk, cytokeratin, CK10
Introduction
An odontogenic keratocyst (OKC) is a benign but lo-
cally aggressive developmental odontogenic cyst, firstly
described in 18761 and named by Phillipsen in 19562. It is
one of the most aggressive odontogenic cysts of the oral
cavity. OKC is known for its rapid growth3–5 and its ten-
dency to invade the adjacent tissues including bone1,5–7.
It has a high recurrence rate5,8,9 and is associated with
the basal cell nevus syndrome10,11. OKC is generally
thought to be derived from either the epithelial rem-
nants of the tooth germ, or the basal cell layer of the sur-
face epithelium12–16. The majority of patients are in the
age ranges of 20–29 and 40–5917, but cases ranging from
5 to 80 years have been reported18,19. Gender distribution
varies from equality to a male to female ratio of 1.6:1, ex-
cept in children18,20–22. OKC may occur in any part of the
upper and lower jaw with the majority occurring in the
mandible, most commonly in the angle of the mandible
and ramus17,18,21,23,24. Radiographically, OKC is presented
predominantly as unilocular radiolucency with well-de-
veloped sclerotic borders. OKC can be associated, al-
though not in all cases, with a previously impacted third
molar25. Radiographically, it appears as a unilocular or
multilocular lesion with a scalloped contour. These char-
acteristics are suggestive but not considered unequivocal
proof for the definitive diagnosis of OKC because other
lesions may exhibit similar features26. In the literature
there is a controversy regarding the treatment of this le-
sion: some surgeons advocate conservative therapies,
whereas others are in favor of an aggressive treatment:
endoscopically assisted enucleation and curettage of large
mandibular odontogenic keratocyst27.Conservative man-
agement includes enucleation, curettage, marsupializa-
tion, and decompression28. Aggressive therapies consist
of enucleation with chemical curettage29 or resection
with or without loss of jaw continuity30.
Cytokeratins are the main structural proteins in epi-
thelial cells comprising a wide series of polypeptides
ranging from 40 to 67 kilodaltons (kD) molecular weight.
They belong to acidic (type I or A) and basic (type II or B)
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sub-families according to their charges, immunoreacti-
vity and amino acid sequences. Cytokeratin patterns dif-
fer in the different types of oral epithelium: the non-
-keratinized stratified squamous epithelium of normal
oral mucosa, from the keratinized epithelium of the
gingiva and from that on the dorsum of the tongue.
Studies done on cytokeratin expression and other tissue
markers in dysplastic and neoplastic oral epithelium led
to the conclusion that the presence of true keratinization
was not a distinguishing feature of keratocysts and that
the more reliable diagnostic features would be the pres-
ence of an accentuated basal cell layer, maturation of the
cells towards the surface and immunohistochemically,
the presence of keratins 8, 18 and 19 in the basal and
suprabasal cells, while some studies have found that the
CK10 staining have to be considered as useful marker in
differential diagnosis of the OKC31–35.
The aims of this study were to: (1) determine the
prevalence of the OKC associated with impacted third
molars, (2) to evaluate OKC reactivity with the antibod-
ies against cytokeratins (CK), particularly for CK10, and
to compare it with reactivity of dentigerous cysts (DC).
Materials and Methods
We have analyzed all operations performed during the
year 2005 at the Clinic for Maxilofacial and Oral Surgery,
University Hospital Dubrava Zagreb. The investigation
was performed using 10 tissue samples, obtained during
the alveotomy of the lower molars. We selected tissue
samples obtained from patients where cyst was clearly
observable near the impacted molar. Tissue material was
divided in two parts. The first part was sent for the usual
PHD examination, and the second part of the material
was selected for the experiment presented herein. The
tissue which was kept for the immunohistochemical in-
vestigations was fixated using the 4% paraformaldehyde.
Additionally, the data from the medical documentation
were examined.
In this study we analyzed OKC reactivity with follow-
ing antibodies obtained by DAKO, Glostrup, Denmark:
Anti-Human Cytokeratin MNF116; Anti-Human Cyto-
keratin 7; Anti-Human Cytokeratin 8; Anti-Human Cyto-
keratins LP34, 34ßE12, 35ßH11; and Anti-Human Cyto-
keratin 10.
In the first part of the data processing, counts and
proportions were calculated. Differences between groups
were established using the (1) c2-test, and (2) relative
risk (RR) – the risk of an event (or of developing a dis-
ease), and associated confidence interval (CI). The level
of the significance of 95% (p<0.05) was applied for all
analyses.
Results and Discussion
In the year 2005, 997 cases of the operative alveo-
tomies associated with impacted molars were done at the
Clinic for Maxilofacial and Oral Surgery, University Hos-
pital Dubrava Zagreb (Table 1). The mandible was signif-
icantly more operated than the maxilla in females and
males. c2-test revealed significant differences between
genders in the operative treatments. More precisely, fe-
male patients were more often involved in the opera-
tional procedures we studied herein. The majority of the
operated patients were within the age range of 20–30,
and the differences between age groups were significant.
The cysts were found in 75 cases and their distribution is
presented in the Figure 1.
When comparing the cysts associated with impacted
molar and its occurrence in upper and lower jaw, the
prevalence of the cysts in the upper jaw is almost twice as
high as the prevalence of the cysts in the lower jaw (sta-
tistically significant). If the comparison is delimited for
the OKC occurrence exclusively, the condition is rever-
ted, but not statistically significant, meaning that the oc-
currence of the OKC in the mandible is twice to that in
maxilla, but because of the delimited degrees of freedom
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TABLE 1
DISTRIBUTION OF ALL OPERATIONS ASSOCIATED WITH IMPACTED MOLARS ACCORIDNG TO GENDER AND AGE OF THE PATIENTS;
c2 SIGNIFICANCE (P – LEVEL OF THE SIGNIFICANCE)
Gender Age (years)
Males (N) Females (N) c² (p) <20 (N) 20–30 (N) 30–40 (N) >40 (N)
Upper jaw 72 142 <0.001 119 599 147 112
Lower jaw 265 498 <0.001
<0.001Total 337 640





Fig 1. Types of cysts found.
(e.g. small sample of cases), the numerical difference did
not reach the appropriate level of statistical significance
(RR=2.24; 95% CI=0.28–17.84; p=0.430).
It is already known that OKCs have a tendency to oc-
cur in any part of the mandible and maxilla, but the ma-
jority, almost 70%, arise in the body of the mandible18.
This is an area common to many benign but aggressive
odontogenic tumors such as ameloblastoma. This is also
a common location for dentigerous cysts and other odo-
ntogenic cysts. For example Lam et al.36 reported that of
the 43 OKCs identified, 25 developed in the mandible
and 18 developed in the maxilla. In their study the major-
ity were associated with a change in either the size or the
shape of the follicular space. Similar occurrences (e.g.
higher occurrence of the OKCs in mandible) are also re-
ported in other studies37–39. Therefore, we can summa-
rize that the date we have found shows consistency with
previous investigations.
If observed separately in females and males, the situa-
tion is as follows: in males, we have found two times hi-
gher risk of cyst occurrence in the upper jaw (RR=1.09;
95% CI=0.12–9.75; p=0.940), and no evident differences
for the OKC (R=1.09; p=0.940). In female patients there
is no observable mandible-maxilla difference in the cyst
occurrence (R=0.89; p=0.510), and for the OKC we have
found numerically evident, but not statistically signifi-
cant risk for the lower jaw (RR=2.57; p=0.790).
When comparing the OKC and other kinds of cysts
the following can be concluded: there is 3.8 times more
frequent OKC occurrence in the mandible than in the
maxilla when operating the impacted third molar (R=3.77;
95% CI=0.50–28.42; p=0.150) – not significant because
of the small sample. We have found almost doubled risk
for the incidence of cysts in males (RR=1.89; p<0.001),
and the risk is somewhat lower for the OKC incidence ex-
clusively (RR=0.16; p=0.184). Comparing this data with
international reports21,40 the overall gender distribution
is virtually identical.
The risk of the cysts’ occurrence increases with age
and the majority of cases have been evidenced in the
fourth decade of life (Odds ratio: 1 vs. 4.46; p<0.001;
when compared to age <20 years – see Figure 2). It is in-
teresting that similar findings are reported in the studies
performed by Chen et al. 20 years ago20 and Woolgar et
al.21, and recently supported by findings of Oda et al.41.
However, for the OKC incidence the situation is re-
versed, and the risk of OKC occurrence decreases with
age with no significant differences between age groups
(see Figure 2). The similar findings were reported in pre-
vious studies. For example, Oda et al.41 reported that the
greatest frequency of the OKC in both genders occurred
in the third life decade (e.g. 20–30 years of age). In the
same study41 authors have found decrease of the OKC oc-
currence in older patients.
In the second part of the study an immunohisto-
chemical analysis on specimens of 5 DC and 5 OKC was
done. Immunohistochemistry was preformed by using
monoclonal antibodies against CK7, CK8, CK10, and the
antibody LP34, 34bE12, 35bH11 that reacts against group
of cytokeratins (CK1, 5, 6, 8, 10, 14 and 18). The reactiv-
ity with antibody LP34, 34bE12, 35bH11 was positive
and equal both with DC and OKC. With antibody against
CK10 reactivity of all DC was negative and with OKC it
was weak and patchy but only with very high concentra-
tions of antibody. Therefore, it is clear that such diagno-
sis cannot be considered reliable and relevant method in
distinguishing between these types of cysts. In other in-
vestigations done with the same objective as we had, au-
thors suggested the possibility of distinguishing the cysts
based on the differential reactivity with the CK10 anti-
body. Briefly, in mentioned studies42–45 the reaction with
the antibody was found for the OKC exclusively. How-
ever, our results do not support the observations that the
CK10 staining has to be considered as a useful marker in
differential diagnosis of the odontogenenic cysts.
Conclusion
In conclusion,
• In 997 cases of the operative alveotomies associated
with impacted molars the mandible was significantly
more operated than the maxilla.
• Cysts were found in 75 cases, and the radicular ones
prevailed (63%), followed by follicular and OKC (13%
and 12% respectively).
• The prevalence of the cysts in the upper jaw is almost
twice as high as the prevalence of the cysts in the man-
dible. If the comparison is delimited for the OKC oc-
currence exclusively the condition is reverted, but – be-
cause of the small sample – not statistically significant.
• There is 3.8 times more frequent OKC occurrence in
the mandible than in the maxilla.
• The risk of the cysts’ occurrence increases with age,
and the broad peak has been observed in the fourth life
decade. On contrary, the risk of OKC occurrence de-
creases with age.
• We could not support the previous findings that the
CK10 staining has to be considered as a useful marker
in differential diagnosis of the odontogenenic cysts.
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Fig. 2. Odds of the cysts’ occurrence in each observed age group.
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PREVALENCIJA ODONTOGENIH KERATOCISTA S IMPAKTIRANIM TRE]IM MOLAROM
S A @ E T A K
U ovom radu analizirana je prevalencija odontogene keratociste (OKC) povezane s impaktiranim tre}im kutnjacima
te evaluirana OKC reaktivnost na antitijela protiv citokeratina (CK), posebice CK10. Uzorci tkiva dobiveni su iz blizine
impaktiranog kutnjaka. Analizirane su razlike po spolu, dobnim skupinama i lokalizaciji ciste, kori{tenjem hi-kvadrat
testa i izra~unavanja relativnog rizika (RR) s intervalima pouzdanosti. Ciste su prona|ene u 75 slu~ajeva, me|u kojima
su prevladavale radikularne (63%), zatim folikularne i OKC (13% i 12%). RR za ciste gornje ~eljusti bio je gotovo dvo-
struko ve}i nego za donju ~eljust. [to se OKC ti~e, RR za gornju ~eljust bio je 1:2- RR za sve ciste je rastao s porastom
dobi pacijenta, dok se smanjivao za OKC. Rizik za nastanak OKC smanjivao se s porastom dobi, no bez statisti~ki
zna~ajnih razlika me|u skupinama. Rezultati ovog istra`ivanja ne potvr|uju da je CK10 bojanje koristan biljeg u di-
ferencijalnoj dijagnozi OKC.
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